Women's health therapeutic (2) - Avion Pharmaceuticals

Drug Profile

Women's health therapeutic (2) - Avion Pharmaceuticals

Latest Information Update: 10 Sep 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Unknown
  • Developer Avion Pharmaceuticals
  • Class
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Female genital diseases

Most Recent Events

  • 09 Sep 2016 No recent reports on development identified - Clinical-Phase-Unknown for Gynaecological disorders in USA (unspecified route)
  • 16 Jun 2014 Clinical trials in Gynaecological disorders in USA (unspecified route) before June 2014
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top